| View |
|
DRP-2366-01
|
Carboplatin
|
Platibene
|
10 mg/mL
|
Solution for Injection (IV)
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
10 June 2024
|
30 July 2025
|
| View |
|
DRP-5051-06
|
Azithromycin (as dihydrate)
|
Zypro
|
200 mg/5 mL
|
Powder for Suspension
|
Antibacterial (Macrolide)
|
Opal Laboratories (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
12 June 2024
|
10 June 2028
|
| View |
|
DRP-5279-06
|
Montelukast (as sodium)
|
Zenkast
|
10 mg
|
Tablet
|
Leukotriene Receptor Antagonist
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
24 April 2029
|
| View |
|
DRP-5301-04
|
Clarithromycin
|
Klarex
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
11 June 2024
|
08 August 2028
|
| View |
|
DRP-5313-02
|
Hydrochlorothiazide
|
Hydropel
|
50 mg
|
Tablet
|
Diuretic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
14 June 2024
|
09 May 2029
|
| View |
|
DRP-5367-12
|
Cefuroxime (as Axetil)
|
Terxime
|
250 mg/5 mL
|
Powder for Oral Suspension
|
Antibacterial
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
30 June 2029
|
| View |
|
DRP-5604-02
|
LETROZOLE
|
FEMABENE
|
2.5 mg
|
Film-Coated Tablet
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
Renewal
|
25 August 2024
|
16 October 2029
|
| View |
|
DRP-5676-02
|
Clindamycin (as phosphate)
|
Clindasan
|
150 mg/mL
|
Solution for Injection (I.M./I.V.)
|
Antibacterial
|
Norris Medicines Limited
|
India
|
CLIDP Conversion
|
15 June 2024
|
29 October 2029
|
| View |
|
DRP-5683-26
|
Cefixime
|
Fixidrops
|
20mg/mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
10 June 2024
|
20 February 2029
|
| View |
|
DRP-5683-27
|
Cefixime
|
Froncef
|
20 mg / mL
|
Granules for Suspension (Oral Drops)
|
Antibacterial
|
J.M. Tolmann Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
11 June 2024
|
20 February 2029
|
| View |
|
DRP-5837-05
|
Tramadol Hydrochloride
|
Amtram-S
|
50 mg
|
Capsule
|
Opioid Analgesic
|
Azarias Pharmaceutical Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
15 June 2024
|
26 November 2024
|
| View |
|
DRP-5909-10
|
Pantoprazole (as sodium sesquihydrate)
|
Pracimed
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
India
|
CLIDP Conversion
|
10 June 2024
|
12 January 2025
|
| View |
|
DRP-6441-02
|
Fluorouracil
|
Urabene
|
50 mg/mL
|
Solution For Injection (IV)
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
12 June 2024
|
21 January 2029
|
| View |
|
DRP-6365-00
|
Amino Acids
|
Celnep-7
|
70 mg/mL (7% w/v)
|
Solution for IV Infusion
|
Parenteral Nutrition
|
Stallion Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 June 2024
|
02 October 2025
|
| View |
|
DRP-6271-01
|
Vincristine sulfate
|
Cristibene
|
1 mg
|
Powder for Solution for Injection (1.V.)
|
Antineoplastic
|
Celon Laboratories Private Limited
|
India
|
CLIDP Conversion
|
12 June 2024
|
18 September 2025
|
| View |
|
DRP-6050-04
|
Rabeprazole Sodium
|
Centrabez
|
20 mg
|
Lyophilized Powder for Injection (IV)
|
Proton Pump Inhibitor
|
Sakar Healthcare Ltd
|
India
|
CLIDP Conversion
|
12 June 2024
|
25 March 2030
|
| View |
|
DRP-6027-07
|
Omeprazole
|
Kodazol
|
40 mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
12 June 2024
|
27 February 2025
|
| View |
|
DRP-5972-05
|
Docetaxel (as trihydrate)
|
Doxetacent
|
20 mg/0.5 mL
|
Concentrate Solution for I.V. Infusion
|
Antineoplastic (Taxane)
|
Getwell Pharma India Pvt. Ltd
|
India
|
CLIDP Conversion
|
15 June 2024
|
28 January 2030
|
| View |
|
DRP-5968-12
|
Hydrocortisone (as sodium succinate)
|
Hydrofed-250
|
250 mg
|
Powder for Injection (IM/IV)
|
Corticosteroid
|
Umedica Laboratories Pvt.Ltd.
|
India
|
CLIDP Conversion
|
15 June 2024
|
29 January 2025
|
| View |
|
DRP-5909-11
|
Pantoprazole (as sodium sesquihydrate)
|
Minacid
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Magbro Healthcare Pvt. Ltd
|
|
CLIDP Conversion
|
11 June 2024
|
12 January 2025
|